Copyright © 2009 Maria Bucova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. P. Holvoet, “Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease,” Verhandelingen Koninklijke Academie voor Geneeskunde van Belgie, vol. 70, no. 3, pp. 193–219, 2008.
2. T. Itoh, Y. Mizuno, E. Harada, M. Yoshimura, H. Ogawa, and H. Yasue, “Coronary spasm is associated with chronic low-grade inflammation,” Circulation Journal, vol. 71, no. 7, pp. 1074–1078, 2007. View at Publisher · View at Google Scholar
3. J.-J. Li, “Inflammation: an important mechanism for different clinical entities of coronary artery diseases,” Chinese Medical Journal, vol. 118, no. 21, pp. 1817–1826, 2005.
4. J. Danesh, D. Phil, J. G. Wheeler, et al., “C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease,” The New England Journal of Medicine, vol. 350, no. 14, pp. 1387–1397, 2004. View at Publisher · View at Google Scholar · View at PubMed
5. J. K. Pai, T. Pischon, J. Ma, et al., “Inflammatory markers and the risk of coronary heart disease in men and women,” The New England Journal of Medicine, vol. 351, no. 25, pp. 2599–2610, 2004. View at Publisher · View at Google Scholar · View at PubMed
6. H. J. Suk, P. M. Ridker, N. R. Cook, and R. Y. L. Zee, “Relation of polymorphism within the C-reactive protein gene and plasma CRP levels,” Atherosclerosis, vol. 178, no. 1, pp. 139–145, 2005. View at Publisher · View at Google Scholar · View at PubMed
7. A. C. St-Pierre, B. Cantin, J. Bergeron, et al., “Inflammatory markers and long-term risk of ischemic heart disease in men: a 13-year follow-up of the Quebec Cardiovascular Study,” Atherosclerosis, vol. 182, no. 2, pp. 315–321, 2005. View at Publisher · View at Google Scholar · View at PubMed
8. M. B. Pepys and G. M. Hirschfield, “C-reactive protein: a critical update,” The Journal of Clinical Investigation, vol. 111, no. 12, pp. 1805–1812, 2003. View at Publisher · View at Google Scholar
9. M. Bucova, M. Bernadic, and T. Buckingham, “C-reactive protein, cytokines and inflammation in cardiovascular diseases,” Bratislavske Lekarske Listy, vol. 109, no. 8, pp. 333–340, 2008.
10. M. Bucova, J. Lietava, F. Mrazek, et al., “Association of chronic stable angina pectoris with MCP-1-2518 A/G single nucleotide polymorphism in the Slovak population,” Clinica Chimica Acta, vol. 392, no. 1-2, pp. 71–72, 2008. View at Publisher · View at Google Scholar · View at PubMed
11. S. L. Deshmane, S. Kremlev, S. Amini, and B. E. Sawaya, “Monocyte chemoattractant protein-1 (MCP-1): an overview,” Journal of Interferon and Cytokine Research, vol. 29, no. 6, pp. 313–326, 2009. View at Publisher · View at Google Scholar · View at PubMed
12. S. T. Tarzami, R. Cheng, W. Miao, R. N. Kitsis, and J. W. Berman, “Chemokine expression in myocardial ischemia: MIP-2 dependent MCP-1 expression protects cardiomyocytes from cell death,” Journal of Molecular and Cellular Cardiology, vol. 34, no. 2, pp. 209–221, 2002. View at Publisher · View at Google Scholar · View at PubMed
13. O. Dewald, Z. Pawel, K. Winkelmann, et al., “CCL2/Monocyte chemoatractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts,” Circulation Research, vol. 96, no. 8, pp. 881–889, 2005.
14. Z. Navratilova, J. Lukac, F. Mrazek, et al., “MCP-1 -2518 A/G single nucleotide polymorphism in Slovak patients with systemic sclerosis,” Mediators of Inflammation, vol. 2008, Article ID 204063, 4 pages, 2008. View at Publisher · View at Google Scholar · View at PubMed
15. G. A. Diamond, H. M. Staniloff, J. S. Forrester, et al., “Computer-assisted diagnosis in the noninvasive evaluation of patients with suspected coronary artery disease,” Journal of the American College of Cardiology, vol. 1, no. 2, part 1, pp. 444–455, 1983.
16. A. Rose and H. Blackburn, Cardiovascular Survey Methods, Monograph Serial, no. 56, World Health Organisation, Geneva, Switzerland, 2nd edition, 1968.
17. S. A. Miller, D. D. Dykes, and H. F. Polesky, “A simple salting out procedure for extracting DNA from human nucleated cells,” Nucleic Acids Research, vol. 16, no. 3, p. 1215, 1988.
18. M. Bunce, C. M. O'Neill, M. C. N. M. Barnardo, et al., “Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 and DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP),” Tissue Antigens, vol. 46, no. 5, pp. 355–367, 1995.
19. Z. Cermakova, J. Petrkova, A. Arakelyan, et al., “The MCP-1 -2518 (A to G) single nucleotide polymorphism is not associated with myocardial infarction in the Czech population,” International Journal of Immunogenetics, vol. 32, no. 5, pp. 315–318, 2005. View at Publisher · View at Google Scholar · View at PubMed
20. E. Simeoni, B. R. Winkelmann, M. M. Hoffmann, et al., “Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis,” European Heart Journal, vol. 25, no. 16, pp. 1438–1446, 2004. View at Publisher · View at Google Scholar · View at PubMed
21. A. J. Szalai, M. A. McCrory, G. S. Cooper, J. Wu, and R. P. Kimberly, “Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene,” Genes and Immunity, vol. 3, no. 1, pp. 14–19, 2002. View at Publisher · View at Google Scholar · View at PubMed
22. D. C. Crawford, C. L. Sanders, X. Qin, et al., “Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey,” Circulation, vol. 114, no. 23, pp. 2458–2465, 2006. View at Publisher · View at Google Scholar · View at PubMed
23. A. J. Szalai, J. Wu, E. M. Lange, et al., “Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level,” Journal of Molecular Medicine, vol. 83, no. 6, pp. 440–447, 2005. View at Publisher · View at Google Scholar · View at PubMed
24. S. Kathiresan, M. G. Larson, R. S. Vasan, et al., “Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level,” Circulation, vol. 113, no. 11, pp. 1415–1423, 2006. View at Publisher · View at Google Scholar · View at PubMed
25. F. D'Aiuto, J. P. Casas, T. Shah, S. E. Humphries, A. D. Hingorani, and M. S. Tonetti, “C-reactive protein (+1444 $\text{C}>\text{T}$) polymorphism influences CRP response following a moderate inflammatory stimulus,” Atherosclerosis, vol. 179, no. 2, pp. 413–417, 2005. View at Publisher · View at Google Scholar · View at PubMed
26. G. Latkovskis, N. Licis, and U. Kalnins, “C-reactive protein levels and common polymorphisms of the interleukin-1 gene cluster and interleukin-6 gene in patients with coronary heart disease,” European Journal of Immunogenetics, vol. 31, no. 5, pp. 207–213, 2004. View at Publisher · View at Google Scholar · View at PubMed
27. M. A. Vickers, F. R. Green, C. Terry, et al., “Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein,” Cardiovascular Research, vol. 53, no. 4, pp. 1029–1034, 2002. View at Publisher · View at Google Scholar
28. J. K. Wolford, J. D. Gruber, V. M. Ossowski, et al., “A C-reactive protein promoter polymorphism is associated with type 2 diabetes mellitus in Pima Indians,” Molecular Genetics and Metabolism, vol. 78, no. 2, pp. 136–144, 2003. View at Publisher · View at Google Scholar
29. J. Dupuis, M. G. Larson, R. S. Vasan, et al., “Genome scan of systemic biomarkers of vascular inflammation in the Framingham Heart Study: evidence for susceptibility loci on 1q,” Atherosclerosis, vol. 182, no. 2, pp. 307–314, 2005. View at Publisher · View at Google Scholar · View at PubMed